Until now, the economic implications of nonadherence to drug therapies have been mostly assessed in a cost perspective and understood as the impact of nonadherence behaviours on the cost-effectiveness ratios of particular therapies. In HIV disease, some modelling approaches have suggested that high adherence levels might improve the cost-effectiveness of highly active antiretroviral treatment regimens. However, there is an urgent need for research directly observing and measuring the costs of nonadherence behaviours. In addition to this cost perspective, the authors argue that the economic impact of nonadherence should also be studied in a microeconomic--patient-oriented--perspective. Major implications of this microeconomic perspective are...
BACKGROUND AND AIMS: The total health care cost for human immunodeficiency virus (HIV) patients has ...
Antiretroviral therapy has dramatically improved the prognosis for many patients with HIV infection....
AbstractBackgroundThe decrement in utility attributable to side effects from combination antiretrovi...
Until now, the economic implications of nonadherence to drug therapies have been mostly assessed in ...
This paper offers an indirect measure of patient welfare based on whether patients comply with the p...
Treatment-naïve advanced HIV-infected patients have a lower life expectancy than those treated early...
In this article, we analyze the rationale for introducing outlier payments into a prospective paymen...
(See the editorial commentary by Johnson on pages 827–8). Clinicians may defer antiretroviral treatm...
BACKGROUND AND OBJECTIVE: The decision to maintain intensive treatment in cardiac surgical patients ...
Introduction: Atrial fibrillation (AF) is a very common condition that causes cardiac rhythm disturb...
textThe rapid growth in the number of drugs approved to treat Human Immunodeficiency Virus (HIV) in...
As health care consumes a growing share of GDP, the demand for better evidence regarding the effects...
BACKGROUND: Pharmacists have demonstrated the ability to improve patient adherence to antiretroviral...
BACKGROUND: Few studies have assessed the eff ect of socioeconomic status on HIV treatment outcome...
Successful antiretroviral therapy (ART) relies on the optimal level of ART adherence to achieve reli...
BACKGROUND AND AIMS: The total health care cost for human immunodeficiency virus (HIV) patients has ...
Antiretroviral therapy has dramatically improved the prognosis for many patients with HIV infection....
AbstractBackgroundThe decrement in utility attributable to side effects from combination antiretrovi...
Until now, the economic implications of nonadherence to drug therapies have been mostly assessed in ...
This paper offers an indirect measure of patient welfare based on whether patients comply with the p...
Treatment-naïve advanced HIV-infected patients have a lower life expectancy than those treated early...
In this article, we analyze the rationale for introducing outlier payments into a prospective paymen...
(See the editorial commentary by Johnson on pages 827–8). Clinicians may defer antiretroviral treatm...
BACKGROUND AND OBJECTIVE: The decision to maintain intensive treatment in cardiac surgical patients ...
Introduction: Atrial fibrillation (AF) is a very common condition that causes cardiac rhythm disturb...
textThe rapid growth in the number of drugs approved to treat Human Immunodeficiency Virus (HIV) in...
As health care consumes a growing share of GDP, the demand for better evidence regarding the effects...
BACKGROUND: Pharmacists have demonstrated the ability to improve patient adherence to antiretroviral...
BACKGROUND: Few studies have assessed the eff ect of socioeconomic status on HIV treatment outcome...
Successful antiretroviral therapy (ART) relies on the optimal level of ART adherence to achieve reli...
BACKGROUND AND AIMS: The total health care cost for human immunodeficiency virus (HIV) patients has ...
Antiretroviral therapy has dramatically improved the prognosis for many patients with HIV infection....
AbstractBackgroundThe decrement in utility attributable to side effects from combination antiretrovi...